Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Non-Small Cell Lung Carcinoma

Known as: Carcinomas, Non-Small-Cell Lung, Non Small Cell Lung Carcinoma, carcinoma cell lung non small 
A group of lung cancers that are named for the kinds of cells found in the cancer and how the cells look under a microscope. The three main types of… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer… Expand
Review
2015
Review
2015
  • M. Cowie
  • European heart journal
  • 2015
  • Corpus ID: 32157207
NICE proposes an update of published guidance if the evidence base or clinical environment has changed to an extent that is… Expand
  • table 1
  • table 3
  • table 6
  • figure 2
  • table 7
Highly Cited
2012
Highly Cited
2012
BACKGROUND Blockade of programmed death 1 (PD-1), an inhibitory receptor expressed by T cells, can overcome immune resistance. We… Expand
  • table 2
  • table 2
Highly Cited
2012
Highly Cited
2012
BACKGROUND Programmed death 1 (PD-1) protein, a T-cell coinhibitory receptor, and one of its ligands, PD-L1, play a pivotal role… Expand
  • table 2
  • figure 1
  • figure 2
Highly Cited
2010
Highly Cited
2010
Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the… Expand
Highly Cited
2008
Highly Cited
2008
PURPOSE Cisplatin plus gemcitabine is a standard regimen for first-line treatment of advanced non-small-cell lung cancer (NSCLC… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Highly Cited
2004
Highly Cited
2004
BACKGROUND Most patients with non-small-cell lung cancer have no response to the tyrosine kinase inhibitor gefitinib, which… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Highly Cited
2004
Highly Cited
2004
Receptor tyrosine kinase genes were sequenced in non–small cell lung cancer (NSCLC) and matched normal tissue. Somatic mutations… Expand
Highly Cited
2004
Highly Cited
2004
BACKGROUND Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, has shown promising preclinical and… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Highly Cited
2002
Highly Cited
2002
CONTEXT Associations have been found between day-to-day particulate air pollution and increased risk of various adverse health… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3